Revenue: As of FY2026 Q1, the actual value is USD 55.93 M, beating the estimate of USD 54.98 M.

EPS: As of FY2026 Q1, the actual value is USD -1.32, missing the estimate of USD -0.0697.

EBIT: As of FY2026 Q1, the actual value is USD -194.46 M.

The provided reference, a Form 8-K filing, indicates that Definitive Healthcare Corp. announced its financial results for the first quarter ended March 31, 2026, via a press release on May 7, 2026. However, the actual financial and operational metrics, including segment revenue, net income, gross margin, operating profit, operating costs, cash flow, or any forward-looking outlook or guidance, are not detailed within this Form 8-K document. The content of the press release (Exhibit 99.1), which contains these details, is not provided in the reference text.